» Articles » PMID: 38352879

Plasticity and Crosstalk of Mesenchymal Stem Cells and Macrophages in Immunomodulation in Sepsis

Overview
Journal Front Immunol
Date 2024 Feb 14
PMID 38352879
Authors
Affiliations
Soon will be listed here.
Abstract

Sepsis is a multisystem disease characterized by dysregulation of the host immune response to infection. Immune response kinetics play a crucial role in the pathogenesis and progression of sepsis. Macrophages, which are known for their heterogeneity and plasticity, actively participate in the immune response during sepsis. These cells are influenced by the ever-changing immune microenvironment and exhibit two-sided immune regulation. Recently, the immunomodulatory function of mesenchymal stem cells (MSCs) in sepsis has garnered significant attention. The immune microenvironment can profoundly impact MSCs, prompting them to exhibit dual immunomodulatory functions akin to a double-edged sword. This discovery holds great importance for understanding sepsis progression and devising effective treatment strategies. Importantly, there is a close interrelationship between macrophages and MSCs, characterized by the fact that during sepsis, these two cell types interact and cooperate to regulate inflammatory processes. This review summarizes the plasticity of macrophages and MSCs within the immune microenvironment during sepsis, as well as the intricate crosstalk between them. This remains an important concern for the future use of these cells for immunomodulatory treatments in the clinic.

Citing Articles

Identification of amino acid metabolism‑related genes as diagnostic and prognostic biomarkers in sepsis through machine learning.

Wen Y, Liu Q, Xu W Exp Ther Med. 2025; 29(2):36.

PMID: 39776890 PMC: 11705229. DOI: 10.3892/etm.2024.12786.


Effects, methods and limits of the cryopreservation on mesenchymal stem cells.

Wang J, Li R Stem Cell Res Ther. 2024; 15(1):337.

PMID: 39343920 PMC: 11441116. DOI: 10.1186/s13287-024-03954-3.

References
1.
He X, Ai S, Guo W, Yang Y, Wang Z, Jiang D . Umbilical cord-derived mesenchymal stem (stromal) cells for treatment of severe sepsis: aphase 1 clinical trial. Transl Res. 2018; 199:52-61. DOI: 10.1016/j.trsl.2018.04.006. View

2.
Bernardo M, Fibbe W . Mesenchymal stromal cells: sensors and switchers of inflammation. Cell Stem Cell. 2013; 13(4):392-402. DOI: 10.1016/j.stem.2013.09.006. View

3.
Li X, Wang S, Zhu R, Li H, Han Q, Zhao R . Lung tumor exosomes induce a pro-inflammatory phenotype in mesenchymal stem cells via NFκB-TLR signaling pathway. J Hematol Oncol. 2016; 9:42. PMC: 4836087. DOI: 10.1186/s13045-016-0269-y. View

4.
Zhang Q, Hwang J, Oh J, Park C, Chung S, Lee Y . Effects of the fibrous topography-mediated macrophage phenotype transition on the recruitment of mesenchymal stem cells: An in vivo study. Biomaterials. 2017; 149:77-87. DOI: 10.1016/j.biomaterials.2017.10.007. View

5.
Song H, Park S, Ko J, Park J, Yoon C, Kim D . Mesenchymal Stromal Cells Inhibit Inflammatory Lymphangiogenesis in the Cornea by Suppressing Macrophage in a TSG-6-Dependent Manner. Mol Ther. 2018; 26(1):162-172. PMC: 5763076. DOI: 10.1016/j.ymthe.2017.09.026. View